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Abstract: Diet and chronic inflammation have been suggested to be risk factors in the development of
cardiovascular disease (CVD) and related mortality. The possible link between the inflammatory
potential of diet measured through the Dietary Inflammatory Index (DII®) and CVD has been
investigated in several populations across the world. The aim of this study was to conduct
a meta-analysis on studies exploring this association. Data from 14 studies were eligible, of which two
were case-control, eleven were cohort, and one was cross-sectional. Results from the random-effects
meta-analysis showed a positive association between increasing DII, indicating a pro-inflammatory
diet, and CVD. Individuals in the highest versus the lowest (reference) DII category showed a 36%
increased risk of CVD incidence and mortality, with moderate evidence of heterogeneity (relative risk
(RR) = 1.36, 95% confidence interval (CI): 1.19, 1.57; heterogeneity index I2 = 69%, p < 0.001).
When analyzed as a continuous variable, results showed an increased risk of CVD risk and mortality
of 8% for each one-point increase in the DII score. Results remained unchanged when analyses were
restricted to the prospective studies. Results of our meta-analysis support the importance of adopting
a healthier anti-inflammatory diet for preventing CVD incidence and related mortality. In conclusion,
a pro-inflammatory diet is associated with increased risk of CVD and CVD mortality. These results
further substantiate the utility of DII as tool to characterize the inflammatory potential of diet and to
predict CVD incidence and mortality.
Keywords: diet; cytokines; nutrition; inflammation; epidemiology; dietary inflammatory index;
cardiovascular diseases; meta-analysis
1. Introduction
Chronic inflammation is characterized by the continuous presence of pro-inflammatory cytokines
through increased blood flow during tissue injury, as a consequence of histamine released by damaged
mast cells [1], and is known to play a major role in the development of cardiovascular diseases
(CVD) and related mortality [2]. Previous research has indicated that whole diet and various dietary
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components have a direct association with inflammation [3–6]. Consumption of fruit and vegetables
has been shown to reduce levels of inflammation, while consumption of red meat has been shown to
increase inflammation [7,8]. Various dietary components also have been implicated in playing a major
role in the development of various CVDs [8–10]. In a recent meta-analysis, increased intake of processed
meat has been shown to be associated with increased risk of CVD mortality [11]. Increased adherence
to healthier dietary patterns characterized by increased intake of plant-based foods such as fruit and
vegetables, nuts, and whole grains and adherence to a healthier dietary pattern has been shown to
help prevent and to manage CVD [12–14]. Finally, an increased intake of polyphenols, anti-oxidants
with ability to decreases oxidative stress and inflammation through scavenging free radicals [15],
was shown to be associated with decreased risk of overall and CVD-related mortality [16].
Until 2009, there was no tool that could take into account the entire diet and determine its
inflammatory potential. Researchers from University of South Carolina have developed a dietary tool
called the Dietary Inflammatory Index (DII®) that places individuals on a continuum from maximally
pro-inflammatory to maximally anti-inflammatory diet. The first version of DII was developed based
on literature published on various dietary components and inflammation through 2007 [17]. In the
first version, 927 peer reviewed articles were scored based on the direction and significance of the
association between various dietary components and each of the six inflammatory markers (C-reactive
protein (CRP); interleukin (IL)-6, -1β, -4, and -10; and tumor necrosis factor (TNF)-α). In 2014, the DII®
was refined and improved with literature review extending through 2010 [18], wherein the number
of articles that were reviewed and scored increased to 1943. The DII categorizes individuals’ diets
according to their inflammatory potential on a continuum from maximal pro-inflammatory to maximal
anti-inflammatory. A higher DII score indicates a more pro-inflammatory diet, whereas a lower DII score
represents a more anti-inflammatory diet. The DII can be calculated from various dietary assessment
tools, with food frequency questionnaires (FFQs) being the most commonly used tool [19–21]. The DII
has been construct validated in several studies, in the first validations study DII has been shown to
be associated with changes in high-sensitivity-CRP in the Seasonal Variation in Blood Cholesterol
Study [17,20]. Subsequently, the DII has been validated in several studies from around the world
with different measures of inflammation such as CRP, IL-6, and TNF-α-R2 [19,22–25]. Apart from the
validation studies, DII has also been shown to be associated with various chronic inflammation-related
health outcomes such as cancer incidence [26–28], all-cause and cancer-specific mortality [29–31],
respiratory conditions such as asthma [32,33] and cognitive disorders [34,35]. In a recent meta-analysis
from nine studies that looked at the association between DII and colorectal cancer (CRC), individuals in
the highest versus the lowest (reference) DII category showed an overall 40% increased risk of colorectal
cancer (CRC), with moderate evidence of heterogeneity (relative risk (RR) = 1.40, 95% confidence
interval (CI): 1.26, 1.55; I2 = 69%, p < 0.001) [36]. Several studies have found positive associations
between DII score and CVD incidence and CVD mortality [9,10,14,37–44]. Using results from qualifying
studies, the purpose of the current meta-analysis was to investigate the cumulative association between
the inflammatory potential of diet, as measured by the DII score, and CVD risk and CVD mortality.
2. Methods
We followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) protocol
throughout the design, execution, analysis and reporting of the present meta-analysis [45].
2.1. Search Strategy and Study Selection
A comprehensive literature search was conducted using PubMed (National Library of Medicine)
and Excerpta Medica database (EMBASE); databases were screened from the earliest available online
indexing year up to September 2017, with Title/Abstract and MESH terms restriction. The following
search terms were included: (dietary inflammatory index or inflammatory diet or anti-inflammatory
diet or dietary score) and (CVD or cardiovascular disease or coronary heart disease (CHD) or ischemic
heart disease (IHD) or myocardial infarction or stroke or heart attack or hypertension). Two authors
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performed the search independently. We included observational studies with any type of design
(prospective, case-control and cross-sectional) that evaluated the association between the DII and
cardiovascular disease risk and mortality. Studies were eligible if they provided corresponding risk
estimates, such as RRs (risk ratios), HRs (hazard ratios), or ORs (odds ratios). We excluded studies
that reported insufficient statistics or evaluated other dietary scores as exposure. Reference lists of
included manuscripts also were “hand searched” for additional studies not previously identified.
When a duplicate report from the same study/cohort was identified, we included the report that
provided the largest number of cases/entire cohort or had the longest follow-up for each endpoint of
interest. Two authors assessed full texts of potentially relevant articles independently.
2.2. Data Extraction
Data were extracted from each eligible study using a standardized extraction form. The following
information was collected: (i) name of the first author; (ii) year of publication; (iii) study cohort or
name; (iv) country; (v) number of participants; (vi) sex of participants; (vii) age range or mean age
of the study population at baseline; (viii) follow-up period; (ix) endpoints and cases; (x) measures
of risk or association with 95% confidence intervals (CIs) for the highest versus the lowest category
of exposure and for one-point increase of the DII score (when available); and (xi) covariates used
for adjustment.
The quality of eligible studies was assessed in accordance to the Newcastle–Ottawa Quality
Assessment Scale [46], which consist of three parameters of quality: selection (four points),
comparability (two points), and outcome (three points), with a score of seven or more points reflecting
high quality.
2.3. Statistical Analysis
In this meta-analysis, ORs and HRs were deemed equivalent to RRs [47]. Random-effects models
were used to calculate pooled RRs (with 95% CIs) of CVD incidence and CVD mortality for the
highest compared to the lowest category of exposure and for a one-point increase in the DII score.
Risk estimates of CVD occurrence and mortality for one-point increase of the DII score (continuous),
were estimated for the studies not reporting the measure but providing sufficient data to estimate
it. Heterogeneity was assessed using the Q test and I2 statistic. The significance for the Q test was
defined as p < 0.10. The I2 statistic represents the amount of total variation that could be attributed to
heterogeneity. I2 values ≤ 25%, 25–50%, 50–75% and >75% indicated no, small, moderate, and high
heterogeneity, respectively. A sensitivity analysis was conducted by excluding one study at the time in
order to assess the stability of results. Subgroup analyses were conducted by type of cardiovascular
event, sex, geographical, and adjustment for body mass index (BMI), smoking, education and physical
activity. Publication bias was assessed by visual observation of funnel plot. All analyses were




The database search identified 63 studies, of which 19 were excluded after reviewing the title,
and 27 based on abstract (Figure 1). Of the remaining 17 publications, three were excluded for the
following reasons: (i) article reported on cardiovascular risk factors, not CVD events; (ii) article did
not report on general population, it used a clinic population with possible prior CVD; and (iii) article
provided data on total/all-cause mortality, from which CVD deaths could not be distinguished.
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Figure 1. Selection of relevant studies reporting on the association between Dietary Inflammatory 
Index (DII®) and cardiovascular disease (CVD) occurrence and mortality. 
For the analysis on the association between DII and CVD risk and mortality, 14 studies were 
eligible [9,10,29,37–44,48–50]. Eleven reports were prospective studies [10,29,37–43,48,49], one study 
had cross-sectional design [50] and two studies were case-control [9,44]. Case-control studies were 
used only for the subgroup analysis of risk of myocardial infarction. Prospective studies included the 
following cohorts: the Iowa Women’s Health Study (IWHS), National Health and Nutrition 
Examination Survey (NHANES)-III study, Swedish Mammography Study, Whitehall II study, 
MONICA/KORA Augsburg study, Supplémentation en Vitamines et Minéraux AntioXydants 
(SU.VI.MAX), The Australian Longitudinal Study on Women's Health (ALSWH), Geelong 
Osteoporosis Study (GOS), Prevención con Dieta Mediterránea (PREDIMED), Seguimiento 
Universidad de Navarra (SUN) and Calcium Intake Fracture Outcome Study (CAIFOS). Studies 
eligible for the meta-analysis comprised 161,337 participants and 15,738 cases. Main characteristics of 
the studies included in the meta-analysis are described in Table 1. Six studies provided relative risk 
for CVD incidence [10,38,39,48–50], six for CVD mortality [29,37,40–43], three for CHD mortality 
[29,37,42], three for IHD/CHD [42,49,50], three for stroke [48–50], four for myocardial infarction 
[9,44,48,49], and two for angina pectoris [48,50]. Three studies were conducted in North America 
[29,43,50], eight in Europe [9,10,39–42,44,48] and three in Australia [37,38,49]. The follow-up time in 
prospective cohort studies ranged from about 4.3 to 26 years. 
Figure 1. Selection of relevant studies reporting on the association between Dietary Inflammatory
Index (DII®) and cardiovascular disease (CVD) occurrence and mortality.
For the analysis on the association between DII and CVD risk and mortality, 14 studies were
eligible [9,10,29,37–44,48–50]. Eleven reports were prospective studies [10,29,37–43,48,49], one study had
cross-sectional design [50] and two studies were case-control [9,44]. Case-control studies were used only
for the sub roup analysis of risk of yocardial infarction. Prospective studies included the following
cohorts: the Iowa Women’s Health Study (IWHS), National Health and Nutrition Examination Survey
(NHA ES)-III study, Swedish Mammogra hy Study, Whitehall II study, MONICA/KORA Augsburg
study, Supplémentation en Vitamines et Minéraux AntioXydant (SU.VI.M X), The Australian
Longitudinal Study on Women's H alth (ALSWH), G elong Ost oporosis Study (GOS), Prevenció con
Dieta Mediterránea (PREDIMED), Seguimiento Universidad de Navarra (SUN) and Calcium Intake
Fracture Outcome Study (CAIFOS). Studies eligible for the meta-analysis comprised 161,337 participants
and 15,738 cases. Main characteristics of the studies included in the meta-analysis are described in Table 1.
Six studies provided relative risk for CVD incidence [10,38,39,48–50], six for CVD mortality [29,37,40–43],
three for CHD mortality [29,37,42], three for IHD/CHD [42,49,50], three for stroke [48–50], four for
myocardial infarction [9,44,48,49], and two for angina pectoris [48,50]. Three studies were conducted
in North America [29,43,50], eight in Europe [9,10,39–42,44,48] and three in Australia [37,38,49].
The follow-up time in prospective cohort studies ranged from about 4.3 to 26 years.
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Table 1. Main characteristics of the studies included in the meta-analysis.

























Age and sex, overweight/obesity, waist-to-height
ratio, total energy intake, smoking status, diabetes,
hypertension, dyslipidemia, family history of
premature cardiovascular disease, physical activity
and educational level.
O’Neil, 2015 [38] Cohort GOS, Australia 5 76 incidentcases; 1363 NA NA M
Age, diabetes, systolic and diastolic blood
pressure (BP), smoking history,
activity level, waist circumference,
and total daily energy consumption.
Ramallal, 2015 [39] Cohort SUN, Spain 8.9 117 incidentcases; 18,794 24/41,240
a 37/42,345 MF
Age, cardiovascular risk factors (hypertension,
dyslipidemia, diabetes, smoking status, family
history of cardiovascular disease), total energy intake,
physical activity, body mass index (BMI), educational
level, and other cardiovascular diseases (tachycardia,
atrial fibrillation, aortic aneurysm, pulmonary
embolism, deep vein thrombosis, peripheral artery
disease, heart valve disease, or pacemaker
placement), special diet at baseline, snacking, average
time sitting, average time spent watching television.
Shivappa, 2015 [29] Cohort IWHS, USA 14 6528 CVDdeaths; 37,525 1615/195,996
a 1665/192,198 F
Age, BMI, smoking status, pack-years of smoking,
HRT use, education, prevalent diabetes,
prevalent hypertension, prevalent heart disease,
prevalent cancer, total energy intake.
Shivappa, 2015 [43] Cohort NHANES III,USA 13.5
1235 CVD
deaths; 12,366 368/4183
b 437/4119 MF Age, sex, race, diabetes status, hypertension,physical activity, BMI, poverty index, and smoking.
Shivappa, 2015 [40] Cohort SMC, Sweden 15 2399 CVDdeaths; 33,747 445/n 560/n F
Age, energy intake, BMI, education, smoking status,
physical activity, and alcohol intake.




Sex, energy intake without alcohol, supplementation
group, number of 24-h records, education level,
marital status, smoking status, physical activity, BMI.




Age, energy, diabetes, hypertension, smoking status,
education, menopausal status and HRT use, physical
activity and alcohol consumption.
Wirth, 2016 [50] Cross-sectional NHANES, USA NA 1734 prevalentcases; 15,693 505/3393 373/3531 MF
Family member smoking status, personal smoking
status, age, and BMI.
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Table 1. Cont.


























210/1056 c 344/1056 MF
Total energy intake, BMI, physical activity, systolic
blood pressure, total serum cholesterol, diabetes,




Australia 15 269 deaths; 1304 55/4368
b 83/4072 F
Age, BMI, energy intake, energy expended in
physical activity, socioeconomic status, use of
low-dose aspirin, use of antihypertensive
medication, use of statins, current or previous
smoking, prevalent ASVD (atherosclerotic
vascular disease) and treatment.
Shivappa, 2017 [44] Case-control NA, Italy NA 682 cases; 682controls 154/171
c 225/171 MF
Age, sex, and total energy intake, education,
tobacco smoking, BMI, occupational physical
activity at age 30–39, coffee consumption,
history of hypertension, history of hyperlipidemia,
history of diabetes and family history of acute
myocardial infarction in first-degree relatives.



















Age, survey, BMI, place of residence,
actual hypertension, education level, diabetes,
physical activity, energy intake, ratio of total
cholesterol and HDL cholesterol, smoking status.
Shivappa, 2017 [41] Cohort Whitehall II, UK 22 264 CVD deaths;7627 84/2456
b 107/2434 MF
Age, sex and ethnicity, occupational grade,
living alone, smoking habits, alcohol consumption,
physical activity, BMI, antecedent of CVD, use of
lipid-lowering drugs, HDL-cholesterol, hypertension,
type 2 diabetes and longstanding illness.
a Denominator is person years of observations; b Denominator is the total number of subject in the DII category; c Denominator is the total number of controls in the DII category.
DII®: Dietary Inflammatory Index; PREDIMED: Prevención con Dieta Mediterránea; GOS: Geelong Osteoporosis Study; SUN: Seguimiento Universidad de Navarra; IWHS: Iowa
Women’s Health Study; NHANES: National Health and Nutrition Examination Survey; SMC: Swedish Mammography Study; SUVIMAX: Supplémentation en Vitamines et Minéraux
AntioXydants; ALSWH: The Australian Longitudinal Study on Women’s Health; NSHDS: Northern Sweden Health and Disease Study; CAIFOS: Calcium Intake Fracture Outcome Study;
NA: not applicable; CVD: cardiovascular disease. HRT: hormone replacement Therapy; HDL: high density lipoproteins; M: male, MF: female.
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3.2. DII and CVD Risk and Mortality
The overall analysis of the association between the DII and CVD (either risk or mortality) is shown
in Figure 2. Individuals in the highest versus the lowest (reference) DII group of exposure had a 36%
increased risk of CVD (RR = 1.36, 95% CI: 1.19, 1.57). There was evidence of heterogeneity (I2 = 65%,
p < 0.001) but no evidence of publication bias after examining the funnel plot (Figure S1). A sensitivity
analysis conducted by excluding one study at a time revealed that the results from the IWHS were the
largest contributor to the heterogeneity and its exclusion reduced heterogeneity to 38% (p = 0.10) with
substantially unchanged effect size (RR = 1.41, 95% CI: 1.24, 1.61). The analysis considering the DII
score as a continuous variable showed an increased risk of CVD of 8% for each one-point increase of
the score (RR = 1.08, 95% CI: 1.04, 1.12) (Figure 3).
Despite that results were affected by heterogeneity, no publication bias was evident after
examination of the funnel plot (Figure S2).
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The analysis for CVD risk and CVD mortality showed similar effect sizes (Figure 2),
with a substantial increased risk of events in individuals with the highest DII compared to the lowest
group (Table 2). However, results for CVD mortality were affected by high heterogeneity (I2 = 77%,
p < 0.001). Assessment of risk estimates for individual outcomes among CVD showed no significant
results besides the association between DII and myocardial infarction; however, statistical power of
these analyses was limited due to the reduced number of available datasets (Table 2).
Table 2. Analyses of studies exploring the association between DII and CVD, total and individual
outcomes. Risk estimates refer to the highest vs. lowest (reference) category of DII.
Subgroup/Additional Analysis No. of Datasets (Studies) RR (95% CI) I2 p
CVD risk and mortality
Total 12 (12) 1.36 (1.19, 1.57) 65% <0.001
CVD risk
Total 6 (6) 1.35 (1.11, 1.63) 36% 0.16
IHD/CHD 3 (3) 1.18 (0.89, 1.58) 37% 0.20
Stroke 3 (3) 1.10 (0.60, 2.00) 65% 0.06
Myocardial infarction 5 (4) 1.43 (1.09, 1.89) 38% 0.17
Angina pectoris 2 (2) 0.79 (0.56, 1.12) 0% 0.73
CVD mortality
Total 6 (6) 1.37 (1.11, 1.70) 77% <0.001
CHD mortality 3 (3) 1.37 (0.88, 2.12) 68% 0.05
IHD: Ischemic Heart Disease; CHD: Coronary Heart Disease.
3.3. Subgroup Analyses
Several subgroups were conducted to assess whether some variables of interest might be
responsible for the heterogeneity observed between results of studies exploring the relation between
DII and CVD (either risk or mortality; Table 3). The analysis revealed that increased risk of CVD in
individuals with high versus low DII was significant only in women and in studies conducted in
Europe and North America, but not in men and studies conducted in Australia (Table 3). Moreover,
among the variables investigated, adjustment for BMI and physical activity was found to be crucial for
obtaining significant results compared to studies that did not adjust for such variables (Table 3).
Table 3. Subgroup analyses of studies exploring the association between DII and CVD (either risk or
mortality). Risk estimates refer to the highest vs. lowest (reference) category of DII.
Subgroup/Additional Analysis No. of Datasets (Studies) RR (Relative Risk) (95% CI) I2 p
Study design
Cross-sectional 1 (1) 1.30 (1.06, 1.58) NA NA
Prospective cohort 11 (11) 1.38 (1.18, 1.62) 68% <0.001
Sex
Male 2 (2) 0.95 (0.70, 1.30) 39% 0.20
Female 5 (5) 1.39 (1.05, 1.82) 86% <0.001
Geographical area
North America 3 (3) 1.25 (1.03, 1.51) 75% 0.02
Europe 6 (6) 1.37 (1.16, 1.61) 0% 0.51
Australia 3 (3) 1.58 (0.93, 2.67) 81% 0.005
Follow-up duration
<10 years 3 (3) 1.85 (1.36, 2.51) 0% 0.89
≥10 years 9 (9) 1.30 (1.12, 1.49) 66% 0.003
Adjusted for smoking
No 0 NA NA NA
Yes 12 (12) 1.36 (1.19, 1.57) 65% <0.001
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Table 3. Cont.
Subgroup/Additional Analysis No. of Datasets (Studies) RR (Relative Risk) (95% CI) I2 p
Adjusted for BMI
No 2 (2) 1.33 (0.71, 2.51) 67% 0.08
Yes 10 (10) 1.39 (1.19, 1.61) 69% <0.001
Adjusted for education
No 5 (5) 1.54 (1.29, 1.83) 41% 0.15
Yes 7 (7) 1.20 (1.04, 1.37) 33% 0.17
Adjusted for physical activity
No 2 (2) 1.16 (0.98, 1.37) 60% 0.11
Yes 10 (10) 1.44 (1.23, 1.67) 42% 0.08
4. Discussion
This meta-analysis, which used results from 14 studies that have examined the association
between the DII and CVD, showed strong evidence of association between increasing inflammatory
potential of diet and CVD risk and related mortality. Therefore, increasing intake of healthy and
anti-inflammatory dietary components such as fruits and green leafy vegetables and decreasing intake
of pro-inflammatory components such as processed meat and sugar-sweetened drinks may play a vital
role in reducing the risk of CVD and related mortality.
Up until the development of the DII, all dietary indices fell into one of three categories: (1) those
based on dietary recommendations such as the Healthy Eating Index-2010 (HEI-2010) [51], or the
Alternative Healthy Eating Index (AHEI) [52], both based on the US Dietary Guidelines or the Dietary
Approaches to Stop Hypertension (DASH) [53], which was promoted by the National Heart, Lung,
and Blood Institute; (2) those related to adherence to a particular foodway or cuisine such as the
Mediterranean Dietary Index (MDI) [54]; or (3) those derived from a particular study using some
kind of regression technique such as principal components analysis or reduced rank regression [55].
These indices have been examined with CVD incidence and mortality as outcome in the past [56].
In a meta-analysis conducted in 2015 that examined results from 15 prospective studies, high-quality
diets, which are indicated by having higher HEI, AHEI, and DASH score, showed a significant risk
reduction (RR) for CVD incidence or mortality (RR = 0.78, 95% CI 0.75 to 0.81; p < 0.00001; I2 = 45%,
95% CI 13% to 66%) [56]. Higher values for each of these indices represent a healthier diet. Each of them
suffers from idiosyncrasies of the approach that include, as a common shortcoming, a narrow range
of exposure variability. None was developed specifically to assess the inflammatory potential of the
diet. By contrast, the DII was designed to reflect all evidence from a wide variety of human populations
as well as from laboratory animal and cell culture experiments. The second advantage of the DII is
that it is grounded in research which involved reviewing and scoring 1943 peer reviewed publications
that looked at the association between various dietary components and inflammatory markers and is
not dependent on a single study or a few studies within the same or similar populations. Results from
a cross-sectional study in the USA indicated that the DII score was negatively correlated with the
previously mentioned dietary indices (HEI-2010 (r = −0.65, p < 0.01), AHEI (r = −0.55, p < 0.01), and the
DASH (r = −0.52, p < 0.01)) [57] and, in large cohort study from Australia, DII was inversely correlated
with the Mediterranean Diet Score (MDS) (r = −0.45, p < 0.01) [58]. Apart from showing strong
and consistent association between increasing DII and CVD risk, the DII has also been successfully
validated with different markers of inflammation in studies across different populations in different
countries [22,25,33,59]. This shows that the DII captures unique properties of diet that are usually not
incorporated in a general healthy diet. Presumably, inflammation is the additional aspect of diet that is
not captured by other dietary indices and patterns. The 45 dietary components used to derive DII are
called food parameters because within this list there are several macro- and micronutrients; food items
such as garlic, ginger and onions; and important bioactive polyphenols such as flavonoids. All six
groups of flavonoids (isoflavones, flavanol, flavan-3-ol, anthocyanidins, flavones and flavanones) are
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included in the DII calculation and all of these have a negative literature-derived inflammatory effect
score [18].
Multiple theories exist that explain the observed consistent association between DII and CVD
risk and related mortality. One of them is the effect of pro-inflammatory diet on increasing levels
of cytokines like IL-1 and TNF-α which, in turn, causes attraction and migration of inflammatory
cells into vascular tissue [60,61]. These inflammatory markers also increase the expression of cellular
adhesion molecules such as selectins and cadherins, which mediate adhesion of white blood cells to
the vascular endothelium [62].
A report published from NHANES-III showed that pro-inflammatory diet was associated with
an increased risk of CVD mortality in addition to all cause and all-cancer mortality among prediabetic
patients [63]. Modified versions of DII have been tested before in relation to CVD risk and mortality.
Georgousopoulou et al., in a study from the ATTICA cohort evaluated the association between
anti-inflammatory diet and 10-year CVD incidence [64]. In this study, authors calculated a modified
version of the DII and have called it Dietary Anti-Inflammation Index (D-AII). The difference between
DII and D-AII is that in the D-AII calculation, the z-scores are not converted to centered percentiles
and instead are directly multiplied by inflammatory effect scores. The scores ranged from 10
to 77. After adjusting for multiple confounding variables, an anti-inflammatory diet, was borderline
significantly inversely associated with 10-year CVD incidence (OR 3rd tertile vs. 1st tertile = 0.98,
95% CI: 0.96–1.01) [64]. Finally, in a report from the Spanish cohort of the European Prospective
Investigation into Cancer and Nutrition (EPIC) study, the authors again have modified the DII and
have called the index Inflammatory Score of Diet (ISD) [65]. The difference between DII and ISD is that
instead of standardizing the intake values to means and standard deviations from the global database,
authors have standardized the intake values to means and standard deviations of the study population.
Subjects classified in the fifth quintile of the ISD (more pro-inflammatory diets) were at higher risk of
cardiovascular diseases mortality (RR = 1.89, 95% CI: 1.48–2.40) as compared with those in the first
quintile [65].
In addition to its strengths, this meta-analysis also has some limitations. First, in the majority
of the studies used for this meta-analysis, DII was derived from dietary assessment tools that were
based on self-report using food frequency questionnaires and 24-h recalls, which carries an inherent
degree of recall bias and can lead to a potential misclassification of the exposure. Second, the DII
score was calculated only once at baseline and human diet might change during study follow-up.
However, previous research has shown that adult dietary patterns seem to be relatively stable over
time [66]. Third, substantial heterogeneity was observed across studies pooling the CVD risk and
mortality. One possible explanation for this could be the differences in the number of food parameters
used to calculate the DII score in different studies; another reason could be the different demographic
characteristics, and follow-up duration across these studies. Finally, only four studies were eligible for
the analysis on CVD risk and six studies for the analysis on CVD mortality.
In conclusion, results from this meta-analysis of a large pool of DII and CVD risk and mortality
studies suggests that increasing inflammatory potential of diet as evidenced by higher DII score was
independently associated with the increased risk of CVD and related mortality. Hence, educating
and encouraging people to consume diets rich in anti-inflammatory food components and low in
pro-inflammatory components should play a crucial role in in reducing the risk of developing CVD.
Future steps would include exploring how a DII compliant dietary intervention (i.e., aiming to lower
overall DII score) would help in preventing newly incident CVD in high-risk populations and in
preventing recurrence among those already living with a CVD.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/10/2/200/s1,
Figure S1: Funnel plot for (a) CVD (cardiovascular disease) occurrence and mortality, (b) CVD occurrence
and c) CVD mortality for the highest versus lowest (reference) category of dietary inflammatory index (DII®);
Figure S2: Funnel plot for (a) CVD occurrence and mortality, (b) CVD occurrence and (c) CVD mortality for
1-point increase of DII.
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